Hadrien A Dyvorne1, Thomas F Barrett2, Bradley N Delman3, Raj K Shrivastava2, and Priti Balchandani1
1Translational and Molecular Imaging Institute, Icahn school of Medicine at Mount Sinai, New York, NY, United States, 2Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, United States, 3Radiology, Icahn school of Medicine at Mount Sinai, New York, NY, United States
Synopsis
Skull
based tumors pose
some of the most complex challenges in neurosurgery owing to their proximity to important structures
such as optic nerves and arteries. For this reason, surgical planning heavily
depends on high quality MR images. In this study we evaluated the performance
of 7T imaging against standard scans at 3T and 1.5T for delineating such
structures. Furthermore, the high-resolution scans were integrated in the
neurosurgical workflow in order to evaluate improvements in surgical time
and confidence of surgical decision-making.Introduction
Tumors arising around
the skull base, such as pituitary adenomas, meningiomas and craniopharyngiomas,
represent approximately 35% of all intracranial tumors (1-3). Because of their
location and proximity to numerous delicate structures, these tumors pose some
of the most complex challenges in neurosurgery(4). By avoiding skin
incision, facial bone flap or craniotomy, endoscopic endonasal surgery (EES) presents
a less externally invasive option for removal of these tumors, resulting in
reduced trauma, decreased morbidity and mortality, and shorter hospital
stays. The success of EES is heavily
dependent on preoperative imaging and detailed evaluation before surgery (5). Magnetic resonance imaging (MRI) at
ultrahigh field strengths, such as 7 Tesla (7T), is particularly effective at
elucidating the delicate vasculature and cranial nerves adjacent to and
involved with tumors as well as tumor composition and extent. The purpose of
this pilot study is to assess the impact of high-resolution 7T anatomical and
vascular imaging for improved surgical planning and navigation.
Methods
MR imaging: In this
IRB-approved prospective study, 10 patients (8 females, age 48 ± 11) with skull
base tumors (7 pituitary adenoma, 1 meningioma, 1 macroadenoma, 1
craniopharyngioma) underwent a high resolution scan on a 7T whole body scanner
(Magnetom, Siemens) equipped with a 32Rx / 1Tx head coil. The following 3 acquisitions
were performed: (i) 3D T1-weighted
Magnetization-Prepared-Rapid-Gradient-Echo (MP2-RAGE) at 0.79 mm isotropic
resolution and TI1/TI2/TR of 1050/3000/6000 s; (ii) Axial, sagittal and coronal
T2-weighted turbo spin echo (TSE) at 0.39 x 0.39 x 2 mm3
resolution, turbo factor 7 and TE/TR 59
/ 6000 ms; (iii) time of flight (TOF) non-contrast angiography at 0.35 x 0.26 x
0.40 mm3 resolution and TE/TR 5.6 / 18 ms. All acquisitions used
parallel imaging acceleration R=2, and total acquisition time was 40-50 min,
including initial localization and calibration scans.
Image
analysis:
Image quality was assessed by an expert neuroradiologist by comparing the 7T series
(uniform T1-weighted (6), T2-weighted and
angiogram) to clinical exams performed either at 3T (n=2 subjects) or a 1.5T
(n=8). A 3-point scale (0 = not visualized, 1 = maybe visualized, 2 =
confidently visualized) was used to assess visualization of the following key structures/features
at each field strength: the pituitary stalk, delineation of normal pituitary
gland from tumor, cranial nerves (CN II-VI) in the plan of the cavernous sinus,
and arteries (OA = ophthalmic, ACA = anterior cerebral, MCA = middle cerebral,
PcomA = posterior communicating, CA = choroidal).
Surgical procedure: All subjects underwent EES after the
MR scans, and 7T images were loaded to the surgical navigation software
(Brainlab) as shown in Fig. 1.
Results
Table 1 summarizes
the performance evaluation of 7T vs. clinical scans for the detection of CNs
and arteries with medium to high confidence (score ≥ 1). All structures were better
visualized at 7T compared to 1.5 and 3T. In addition, gland-tumor delineation
was observed in 7/10 patients at 7T while only observed in 2/8 patients at 1.5T
and not visible at 3T (0/2 patients).
Figure
2 displays a sagittal view of the high resolution TSE of a meningioma
patient at 7T, showing the large number of fine structures visible around the
tumor.
Figure 3 shows example images
comparing 7T to 3T scans in two patients with pituitary adenomas. Both nerves
and arteries appear more conspicuous on the higher resolution 7T images.
Discussion and conclusion
As summarized in
Table 1 and shown in
Figures 2 and 3, many of the nerves, arteries and other structures proximal to
the tumor, critical to surgical planning and resection, are often clearly
resolved at 7T and insufficiently resolved at 1.5T and 3T. 7T imaging can be
seamlessly integrated into neurosurgical planning and projected on the surgical
navigation systems for guidance in the operating room. Using 7T, surgeons qualitatively
reported a significant increase (approx. 50%) in confidence of critical
decisions determining resection method, as well as decreased need for invasive
procedures such as extensive drilling, which resulted in the total surgical
time shortening on average from 179 mins (mean of 30 previous similar cases) to
125 mins (31%). The results of this work are immediately applicable to
neurosurgical planning and guidance for brain tumors and could lead to the
integration of 7T imaging into standard surgical procedure for other neurological
conditions. The next phase of this study will be to perform a randomized
clinical trial with a larger cohort, using a quantitative scale to assess improvement
of neurosurgical efficacy as well as patient outcome after the integration of
this technology.
Acknowledgements
Funding sources: Icahn School of Medicine Capital Campaign.References
1. Asa
SL, Ezzat S. The pathogenesis of pituitary tumours. Nature Reviews Cancer.
2002;2(11):836-49.
2. Chernov M, DeMonte F.
Skull base tumors. Cancer in the nervous system, second edition, Oxford. 2002.
3. Ostrom QT, Gittleman H,
Liao P, Rouse C, Chen Y, Dowling J, et al. CBTRUS statistical report: primary
brain and central nervous system tumors diagnosed in the United States in
2007–2011. Neuro-oncology. 2014;16(suppl 4):iv1-iv63.
4. Cappabianca P, Califano L,
Iaconetta G. Cranial, craniofacial and skull base surgery: Springer; 2010.
5. Liu JK, Das K, Weiss MH,
Laws Jr ER, Couldwell WT. The history and evolution of transsphenoidal surgery.
Journal of neurosurgery. 2001;95(6):1083-96.
6. Marques JP, Kober T,
Krueger G, van der Zwaag W, Van de Moortele PF, Gruetter R. MP2RAGE, a self
bias-field corrected sequence for improved segmentation and T1-mapping at high
field. Neuroimage. 2010;49(2):1271-81.